Transcode Therapeutics RNAZ
NASDAQ RNAZ
$2.87 -0.10 (-3.37%)
At close: Aug 21, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Property, Plant & Equipment (Net) (2021 - 2026)

Transcode Therapeutics (RNAZ) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Transcode Therapeutics 2.84 Mn 2.84 Mn - 322,809.00

Historic Data

Download Data
DateValue
Mar 31, 2026 346,745.00
Mar 31, 2026 346,745.00
Dec 31, 2025 370,681.00
Dec 31, 2025 370,681.00
Sep 30, 2025 19,908.00
Sep 30, 2025 19,908.00
Jun 30, 2025 24,689.00
Jun 30, 2025 24,689.00
Mar 31, 2025 38,131.00
Mar 31, 2025 38,131.00
Dec 31, 2024 51,574.00
Dec 31, 2024 51,574.00
Sep 30, 2024 61,420.00
Sep 30, 2024 61,420.00
Jun 30, 2024 64,581.00
Jun 30, 2024 64,581.00
Mar 31, 2024 92,379.00
Mar 31, 2024 92,379.00
Dec 31, 2023 120,707.00
Dec 31, 2023 120,707.00